(Total Views: 476)
Posted On: 09/06/2021 10:59:19 PM
Post# of 151766
Quote:
They spoke in some detail about the potential of forming partnerships for cancer combo-therapy, which they seemed to think could be a source of quick revenue.
Cancer trials take quite a bit of time so there is no quick revenue. As for quick funding BP isn't going to want one indication they'll want them all. A partnership with a small BP means very little upfront money and a disastrous split on revenue for Cytodyn. If the 13d expect otherwise they're a bit muddleheaded.
(8)
(0)Scroll down for more posts ▼
